Holen Sie sich die Stockscreener-App
10.66
132.24%
6.07
Handel nachbörslich:
10.73
0.07
+0.66%
Schlusskurs vom Vortag:
$4.59
Offen:
$10.7
24-Stunden-Volumen:
3.93M
Relative Volume:
17.72
Marktkapitalisierung:
$16.61M
Einnahmen:
$8.62M
Nettoeinkommen (Verlust:
$-6.15M
KGV:
-0.9665
EPS:
-11.03
Netto-Cashflow:
$-5.32M
1W Leistung:
+117.55%
1M Leistung:
+133.20%
6M Leistung:
+244.98%
1J Leistung:
+86.36%
1-Tages-Spanne:
$10.66
$10.79
1-Wochen-Bereich:
$4.5001
$10.79
52-Wochen-Spanne:
$1.94
$10.79
Evoke Pharma Inc Stock (EVOK) Company Profile
Firmenname
Evoke Pharma Inc
Sektor
Telefon
858-345-1494
Adresse
420 STEVENS AVENUE, SOLANA BEACH, CA
Vergleichen Sie EVOK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
10.66 | 7.15M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
124.46 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.56 | 42.40B | 29.63B | 260.53M | 4.77B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.32 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.46 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.33 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-06-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | Fortgesetzt | FBR & Co. | Buy |
| 2017-03-16 | Bestätigt | Rodman & Renshaw | Buy |
| 2017-01-30 | Hochstufung | Laidlaw | Neutral → Buy |
| 2017-01-05 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | Bestätigt | Rodman & Renshaw | Neutral |
| 2016-07-19 | Bestätigt | FBR Capital | Outperform |
| 2016-07-19 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-07-18 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | Eingeleitet | Northland Capital | Outperform |
| 2016-03-14 | Bestätigt | Ascendiant Capital Markets | Buy |
| 2016-02-17 | Fortgesetzt | FBR Capital | Outperform |
| 2014-12-03 | Bestätigt | MLV & Co | Buy |
| 2014-11-07 | Eingeleitet | MLV & Co | Buy |
| 2014-04-22 | Eingeleitet | Laidlaw | Buy |
| 2013-11-19 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten
Latham & Watkins Advises Evoke Pharma on Acquisition by QOL Medical - Latham & Watkins
How to read the order book for Evoke Pharma Inc.Market Activity Recap & Proven Capital Preservation Tips - newser.com
Using economic indicators to assess Evoke Pharma Inc. potentialJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
QOL Medical to acquire Evoke Pharma for $11 per share in cash deal - Investing.com India
Evoke Pharma soars on announcement to be acquired by QOL Medical - MSN
Evoke Pharma Shares Skyrocket 134% After QOL Medical Announces Acquisition Deal - MSN
Mergers And Earnings Send Several Stocks Racing Higher - Finimize
[SC TO-C] Evoke Pharma Inc Tender Offer Communication | EVOK SEC FilingForm SC TO-C - Stock Titan
Gold Falls Over 1%; Uber Shares Decline After Q3 Results - Benzinga
Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire
Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal - Benzinga
EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders - The Joplin Globe
Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga
Evoke Pharma (EVOK) Soars Over 130% on Acquisition News - GuruFocus
Why Is Evoke Pharma Stock (EVOK) Up 135% Today? - TipRanks
QOL Medical to Acquire Evoke Pharma (EVOK) at Significant Premiu - GuruFocus
Evoke Pharma enters into definitive agreement to be acquired by QOL Medical - MarketScreener
Evoke Pharma Announces Merger with QOL Medical - TipRanks
Evoke Pharma stock soars after QOL Medical acquisition announcement By Investing.com - Investing.com Philippines
Evoke Pharma stock soars after QOL Medical acquisition announcement - Investing.com
Analyzing Evoke Pharma Inc. with risk reward ratio charts2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical - The Manila Times
Evoke Pharma (NASDAQ: EVOK) to be acquired for $11.00/share; tender offer, closing in 2025 - Stock Titan
Candlestick signals on Evoke Pharma Inc. stock todayJuly 2025 Breakouts & Daily Volume Surge Signals - newser.com
Risk vs reward if holding onto Evoke Pharma Inc.2025 Sector Review & Community Consensus Trade Alerts - newser.com
Quantitative breakdown of Evoke Pharma Inc. recent moveSell Signal & Daily Growth Stock Investment Tips - newser.com
Evoke Pharma Inc expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Using Bollinger Bands to evaluate Evoke Pharma Inc.Portfolio Value Summary & Stepwise Swing Trade Plans - newser.com
Top chart patterns to watch in Evoke Pharma Inc.2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Will Evoke Pharma Inc. stock continue dividend increasesJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
Identifying reversal signals in Evoke Pharma Inc.July 2025 PreEarnings & Intraday High Probability Setup Alerts - newser.com
How currency fluctuations impact Evoke Pharma Inc. stockWeekly Trend Summary & Expert Verified Stock Movement Alerts - newser.com
Price action breakdown for Evoke Pharma Inc.Fed Meeting & Fast Gain Stock Tips - newser.com
Press Release: Evoke Pharma Enters Into Definitive Agreement to Be Acquired by QOL Medical - 富途牛牛
Why Evoke Pharma Inc. stock is a value investor pickJuly 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Will Evoke Pharma Inc. rebound enough to break evenJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
How sustainable is Evoke Pharma Inc. stock dividend payoutJuly 2025 Spike Watch & Daily Market Momentum Tracking - newser.com
Evaluating Evoke Pharma Inc. with trendline analysisJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Key metrics from Evoke Pharma Inc.’s quarterly dataDay Trade & Free Community Consensus Stock Picks - newser.com
Will Evoke Pharma Inc. stock go up soonJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stock2025 Big Picture & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Evoke Pharma Inc.2025 Performance Recap & Fast Entry High Yield Tips - newser.com
How Evoke Pharma Inc. stock responds to policy changesQuarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.60%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):